Home About us Products Technology Contact Distributors Literature News ENABLING MOLECULAR DIAGNOSTICS RAPID MOLECULAR TESTING FOR CLINICAL DIAGNOSTICS Abacus Diagnostica’s proprietary, fully automated testing platform GenomEra® CDX takes molecular testing to a new level of easiness and speed without compromising the quality of results. COST EFFICIENT AUTOMATED SOLUTION All-in-one PCR and RT-PCR test chips with homogeneous detection in fully automated instrument. Reducing the costs by affordable pricing, robust assays and long service intervals. CE IVD TESTS FOR INFECTIOUS DISEASES Critical human pathogens and antibiotic resistance markers such as C. difficile, Norovirus and MRSA OUR PRODUCTS GenomEra CDX system has proven to be one of the fastest, easiest-to-use and the most cost-effective automated solution for molecular diagnostics (MDx) of infectious diseases. GenomEra is suitable also for small to mid-size customers without any prior experience in MDx. See all products GENOMERA® CDX SYSTEM Easy-to-use automated assay platform. NOROVIRUS Cost-effective and reliable method for on-demand testing of norovirus FLU A/B + RSV Rapid detection and differentiation of Flu A, Flu B, RSV A and RSV B SARS-COV-2 Rapid and reliable detection of SARS-CoV-2 SARS-COV-2, FLU A/B + RSV Rapid detection and differentiation of SARS-CoV-2, Flu A, Flu B, and RSV RUO SARS-COV-2 + VOC Rapid detection and differentiation of SARS-CoV-2 and clinically significant deletions present in the variants of concern MRSA/SA AC Rapid detection of SA and MRSA from blood cultures and colonies. MRSA/SA MULTI SWAB Sensitive MRSA screening from nose and multiple anatomical sites. C. DIFFICILE Rapid detection of toxigenic C. difficile direct from stool. GBS (GROUP B STREPTOCOCCUS) Rapid screening of GBS from broth samples. NEWS Abacus Diagnostica, Kaivogen ja Labrox yhdistyvät Abacus Diagnostica, Kaivogen ja Labrox yhdistyvät ja muodostavat edelläkävijän globaaleille diagnostiikkamarkkinoille – Tavoitteena oikea diagnoosi sekä hoito ensimmäisellä potilaskäynnillä Turkulaiset biotekniikan huippuosaajat Abacus Diagnostica, Kaivogen ja Labrox ovat yhdistymässä kansainväliseksi diagnostiikkaratkaisujen edelläkävijäksi. Uusi yhtiö tulee tarjoamaan globaaleille markkinoille ainutlaatuisen vieritestauksen kokonaisratkaisun muun muassa infektio- ja syöpäsairauksien diagnostiikkaan. Se tuo yhteen maailman kärkeä olevan laite- ja kemiaosaamisen sekä tarjoaa terveydenhuollolle ja potilaille entistä nopeampaa, helpompaa ja kustannustehokkaampaa sairauksien tunnistamista. Yhdistyminen on tarkoitus saada päätökseen lokakuussa. Yhtiön nimi tullaan päättämään kuluvan syksyn aikana. Taustalla olevilla kasvuyhtiöllä on vuosien kokemus diagnostiikan markkinoista: Abacus Diagnostica on molekyylitestauksen ja pika-PCR-testijärjestelmien suunnannäyttäjä, Kaivogen on immunomääritysten ja vasta-ainetestien erikoisosaaja ja Labrox on innovatiivinen laboratorioinstrumenttien kehittäjä. Lehdistötiedote Abacus Diagnostica, Kaivogen and Labrox joining forces to form a global diagnostics pioneer – Enabling the right diagnosis and care at the patient’s first appointment Three Finnish biotech companies – Abacus Diagnostica, Kaivogen, and Labrox – are joining forces to form an international frontrunner in in vitro diagnostics. The new company will provide the global market with a unique total solution for point-of-care testing, including diagnostics for infectious diseases and cancers. It brings together some of the world’s leading instrumentation and biochemical knowhow, and it will offer healthcare providers and patients faster, easier and more cost-effective diagnostics. The transaction is to be completed in October. The name of the company will be decided during this autumn. The three growth companies have years of experience in diagnostics: Abacus Diagnostica is a frontrunner in molecular testing and rapid PCR tests, Kaivogen specialises in immunoassays and antibody tests, and Labrox is an innovative developer of laboratory instruments. Press release Open position / Avoin työpaikka: Clinical Study Manager We are looking for a Clinical Study Manager to join our team. Job post Etsimme joukkoomme Clinical Study Manageria. Työpaikkailmoitus Open position: Marketing Director We are looking for a Marketing Director to join our team. Apply by 30.05.2021 Job post on LinkedIn Abacus Diagnostica Oy ElectroCity Tykistökatu 4 D, 2nd floor 20520 Turku, FINLAND Tel: + 358 (0)20 7188 380 E-mail: info, sales, support *(at)abacusdiagnostica.com